In a groundbreaking advancement, researchers from the University of Pittsburgh, in collaboration with Cornell University, have engineered a self-destructing intravenous (i.v.) Bacillus Calmette-Guérin (BCG) vaccine. This innovative vaccine has shown promising results in preclinical trials,offering enhanced safety and protection against tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) in macaque monkeys. The newly developed vaccine incorporates […]
You can read the full story here: New Safer TB Vaccine with BCG Kill Switch Protects Mice and Monkeys.